Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing
Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
Who this might be right for
HIV Infection
Theravectys S.A. 38